# Scheduled Intranasal Ketamine

> **NCT05671913** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Sanford Health**

## Conditions studied

- Pain
- Trauma

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05671913
- **Lead sponsor:** Sanford Health
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Funding not acquired to run the study.
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05671913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05671913, "Scheduled Intranasal Ketamine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05671913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*